MARKET

ABBV

ABBV

Abbvie Inc
NYSE
209.40
-1.72
-0.81%
Pre Market: 209.05 -0.35 -0.17% 05:27 03/30 EDT
OPEN
211.42
PREV CLOSE
211.12
HIGH
213.49
LOW
209.12
VOLUME
336
TURNOVER
--
52 WEEK HIGH
241.12
52 WEEK LOW
159.05
MARKET CAP
370.38B
P/E (TTM)
88.69
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ABBV last week (0323-0327)?
Weekly Report · 50m ago
Assessing AbbVie (ABBV) Valuation After New Dermatology Data Underpins Immunology Growth Potential
Simply Wall St · 3h ago
AbbVie Dermatology Data Highlights Immunology Depth And Emerging Skin Disease Opportunities
Simply Wall St · 1d ago
1 Reason Eli Lilly Stock Is Still a Buy
NASDAQ · 1d ago
AbbVie call volume above normal and directionally bullish
TipRanks · 2d ago
AbbVie: Strong 2026 Outlook, Expect Dividend Increases
Seeking Alpha · 2d ago
AbbVie’s Global IBD Outcomes Study: What Treat-to-Target Data Could Mean for Investors
TipRanks · 2d ago
AbbVie’s US HARMONY in DIVERSITY Study Highlights Cross‑Brand Aesthetics Strategy
TipRanks · 2d ago
More
About ABBV
AbbVie Inc. is a global, diversified research-based biopharmaceutical company. It is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. Its product portfolio includes Immunology, Oncology, Aesthetics, Neuroscience, Eye Care and Other Key Products. Immunology products include rheumatology, dermatology and gastroenterology. Oncology products include Imbruvica, Venclexta/Venclyxto, Elahere and Epkinly. Aesthetics portfolio consists of facial injectables, plastics and regenerative medicine, body contouring, and skincare products. Its Neuroscience products include Botox Therapeutic, Vraylar, Duopa and Duodopa, Ubrelvy, and Qulipta. Eye Care products include Ozurdex, Lumigan/Ganfort, Alphagan/Combigan, Restasis, and other eye care. Other key products include Mavyret/Maviret, Creon, and Linzess/Constella. Its investigational candidate, bretisilocin, is for the treatment of patients with moderate-to-severe major depressive disorder (MDD).

Webull offers AbbVie Inc stock information, including NYSE: ABBV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABBV stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ABBV stock methods without spending real money on the virtual paper trading platform.